BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 1/13/1994

Opportunity for a License for Nonpatented Material

The Centers for Disease Control and Prevention (CDC) is offering a license for recombinant proteins and synthetic peptides to be used as immunodiagnostic reagents for detecting Hepatitis C Virus (HCV) antibodies.

Original source language: Federal Register — Health and Human ServicesOpen original release →